Evidence map›Paper›PMID 42883933›Full record

ArticleInternational journal of molecular sciences2026

piR-823 and piR-20326 Differentially Regulate Stemness Programs in Ovarian Cancer Stem-like Cells.

Ece Gumusoglu-Acar, Sude Sultan Ozdemir, Uygar Yucekaya, Ronald J Buckanovich, Tuba Gunel

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ece Gumusoglu-AcarDepartment of Molecular Biology and Genetics, Faculty of Science, Istanbul University, Bozdogankemeri St., No. 1., 34134 Istanbul, Turkey.ORCID 0000-0003-3807-0330
Sude Sultan OzdemirDepartment of Molecular Biotechnology and Genetics, Institute of Graduate Studies in Sciences, Istanbul University, 34116 Istanbul, Turkey.
Uygar YucekayaDepartment of Molecular Biotechnology and Genetics, Institute of Graduate Studies in Sciences, Istanbul University, 34116 Istanbul, Turkey.ORCID 0009-0000-0708-1518
Ronald J BuckanovichMagee-Womens Research Institute, Pittsburgh, PA 15213, USA.ORCID 0000-0002-5665-9790
Tuba GunelDepartment of Molecular Biology and Genetics, Faculty of Science, Istanbul University, Bozdogankemeri St., No. 1., 34134 Istanbul, Turkey.ORCID 0000-0003-3514-5210

Funding

Project 3: Hedgehog Inhibition to Enhance Response to ICI TherapyP50CA272218 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FRANCESMARY MODUGNO · 2023 to 2026
$11.0M
Istanbul University 32581Istanbul University 40170NCI NIH HHS P50 CA272218Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 122Z268
6 · The paper itself

Abstract

Ovarian cancer stem-like cells (OCSCs) are major drivers of tumor recurrence and chemoresistance. Although PIWI-interacting RNAs (piRNAs) have emerged as important regulators of cancer stem cell (CSC) biology, their roles in OCSCs remain poorly understood. We performed a systematic analysis of public datasets to identify ovarian cancer-associated piRNAs and selected piR-823 and piR-20326 for functional validation. Their expression was evaluated by quantitative reverse transcription polymerase chain reaction (qRT-PCR)following piRNA mimic and inhibitor transfections in three-dimensional (3D) ovarian cancer spheroids and ALDH

Indexed as

Neoplastic Stem CellsOvarian NeoplasmsPiwi-Interacting RNARNA, Small InterferingAC133 AntigenCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansSpheroids, CellularAC133 AntigenPiwi-Interacting RNARNA, Small Interferingcancer stem cellsovarian cancerpiR-20326piR-823piRNA

Identifiers

PMID42883933
PMCPMC13665198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.